MISSISSIPPI LEGISLATURE
2001 Regular Session
To: Judiciary
By: Senator(s) Huggins
Senate Bill 2213
(As Passed the Senate)
AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO REVISE THE LIST OF SCHEDULE I CONTROLLED SUBSTANCES; TO AMEND SECTION 41-29-117, MISSISSIPPI CODE OF 1972, TO REVISE THE LIST OF SCHEDULE III CONTROLLED SUBSTANCES; TO AMEND SECTION 41-29-119, MISSISSIPPI CODE OF 1972, TO REVISE THE LIST OF SCHEDULE IV CONTROLLED SUBSTANCES; AND FOR RELATED PURPOSES.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI:
SECTION 1. Section 41-29-113, Mississippi Code of 1972, is amended as follows:
41-29-113. The controlled substances listed in this section are included in Schedule I.
SCHEDULE I
(a) Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl;
(2) Acetylmethadol;
(3) Allylprodine;
(4) Alphacetylmethadol, except levo-alphacetylmethadol (levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);
(5) Alphameprodine;
(6) Alphamethadol;
(7) Alpha-methylfentanyl;
(8) Alpha-methylthiofentanyl;
(9) Benzethidine;
(10) Betacetylmethadol;
(11) Beta-hydroxyfentanyl;
(12) Beta-hydroxy-3-methylfentanyl;
(13) Betameprodine;
(14) Betamethadol;
(15) Betaprodine;
(16) Clonitazene;
(17) Dextromoramide;
(18) Diampromide;
(19) Diethylthiambutene;
(20) Difenoxin;
(21) Dimenoxadol;
(22) Dimepheptanol;
(23) Dimethylthiambutene;
(24) Dioxaphetyl butyrate;
(25) Dipipanone;
(26) Ethylmethylthiambutene;
(27) Etonitazene;
(28) Etoxeridine;
(29) Furethidine;
(30) Hydroxypethidine;
(31) Ketobemidone;
(32) Levomoramide;
(33) Levophenacylmorphan;
(34) 3-methylfentanyl;
(35) 3-methylthiofentanyl;
(36) Morpheridine;
(37) Noracymethadol;
(38) Norlevorphanol;
(39) Normethadone;
(40) Norpipanone;
(41) Para-fluorofentanyl;
(42) Phenadoxone;
(43) Phenampromide;
(44) Phenomorphan;
(45) Phenoperidine;
(46) Piritramide;
(47) Proheptazine;
(48) Properidine;
(49) Propiram;
(50) Racemoramide;
(51) Tilidine;
(52) Trimeperidine;
(53) Thiofentanyl;
(54) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
(55) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP).
(b) Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Acetorphine;
(2) Acetyldihydrocodeine;
(3) Benzylmorphine;
(4) Codeine methylbromide;
(5) Codeine-N-Oxide;
(6) Cyprenorphine;
(7) Desomorphine;
(8) Dihydromorphine;
(9) Drotebanol;
(10) Etorphine; (except hydrochloride salt);
(11) Heroin;
(12) Hydromorphinol;
(13) Methyldesorphine;
(14) Methyldihydromorphine;
(15) Monoacetylmorphine;
(16) Morphine methylbromide;
(17) Morphine methylsulfonate;
(18) Morphine-N-Oxide;
(19) Myrophine;
(20) Nicocodeine;
(21) Nicomorphine;
(22) Normorphine;
(23) Pholcodine;
(24) Thebacon.
(c) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) 3, 4-methylenedioxy amphetamine;
(2) 5-methoxy-3, 4-methylenedioxy amphetamine;
(3) 2, 5-dimethoxy-4-ethylamphetamine (DOET);
(4) 3, 4-methylenedioxymethamphetamine (MDMA);
(5) 3, 4, 5-trimethoxy amphetamine;
(6) Bufotenine;
(7) Diethyltryptamine;
(8) Dimethyltryptamine;
(9) Alpha-ethyltryptamine;
(10) 4-methyl-2, 5-dimethoxyamphetamine;
(11) Hashish;
(12) Ibogaine;
(13) Lysergic acid diethylamide; (LSD)
(14) Marihuana;
(15) Mescaline;
(16) Peyote;
(17) N-ethyl-3-piperidyl benzilate;
(18) N-methyl-3-piperidyl benzilate;
(19) Phencyclidine;
(20) Psilocybin;
(21) Psilocyn;
(22) Tetrahydrocannabinols (excluding dronabinol and nabilone);
(23) 2, 5-dimethoxyamphetamine;
(24) 4-bromo-2, 5-dimethoxyamphetamine;
(25) 4-bromo-2, 5-dimethoxyphenylethylamine;
(26) 4-methoxyamphetamine;
(27) Ethylamine analog of phencyclidine (PCE);
(28) Pyrrolidine analog of phencyclidine (PHP, PCPy);
(29) Thiophene analog of Phencyclidine;
(30) Parahexyl;
(31) 1-[1-(2-Thienyl)cyclohexyl] pyrrolidine (TCPy);
(32) 3, 4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3, 4 (methylenedioxy) phenylethylamine, N-ethyl MDA, MDE and MDEA);
(33) N-hydroxy-3, 4-methylenedioxyamphetamine (also known as N-hydroxy MDA, N-OHMDA, and N-hydroxy-alpha-methyl-3, 4-(methylenedioxy) phenylethylamine).
(d) Mecloqualone, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of the salts, isomers and salts of isomers is possible within this specific chemical designation.
(e) Gamma-hydroxybutyric acid (other names include: GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanuic acid; sodium oxybate; sodium oxybutyrate), including its salts, isomers, and salts of isomers.
(f) Any material, compound, mixture or preparation which contains any quantity of the following central nervous system stimulants including salts, isomers and salts of isomers unless specifically excepted or unless listed in another schedule:
(1) Aminorex;
(2) Cathinone;
(3) Fenethylline;
(4) N-ethyl-amphetamine;
(5) 4-methylaminorex (also known as 2-amino-4-methyl-5-phenyl-2-oxazoline);
(6) Methacathinone.
(g) Any material, compound, mixture or preparation which contains any quantity of methaqualone, including its salts, isomers, optical isomers, salts of their isomers and salts of their optical isomers unless specifically excepted or unless listed in another schedule.
(h) Any material, compound, mixture or preparation which contains any quantity of N,N-dimethylamphetamine, including its salts, isomers and salts of isomers, unless specifically excepted or unless listed in another schedule. (Other names include: N,N, alpha-trimethylbenzene-ethaneamine, and N,N, alpha-trimethylphenylethylamine).
SECTION 2. Section 41-29-117, Mississippi Code of 1972, is amended as follows:
41-29-117. (A) The controlled substances listed in this section are included in Schedule III.
SCHEDULE III
(a) Any material, compound, mixture, or preparation which contains any quantity of the following substances or their salts, isomers, or salts of isomers, of the following substances:
(1) Benzphetamine;
(2) Chlorphentermine;
(3) Clortermine;
(4) Phendimetrazine.
(b) Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
(1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules.
(2) Unless specifically excepted or unless listed in another schedule, any compound, mixture or preparation containing any of the following substances or any salt of the substances specifically included in this subsection (2) and one or more other active medicinal ingredients which are not listed in any other schedule:
(i) Amobarbital;
(ii) Secobarbital;
(iii) Pentobarbital.
(3) Any suppository dosage form containing any of the following substances or any salt of any of the substances specifically included in this subsection (3) approved by the Food and Drug Administration for marketing only as a suppository:
(i) Amobarbital;
(ii) Secobarbital;
(iii) Pentobarbital.
(4) Chlorhexadol;
(5) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug and Cosmetic Act;
(6) Lysergic acid;
(7) Lysergic acid amide;
(8) Methyprylon;
(9) Sulfondiethylmethane;
(10) Sulfonethylmethane;
(11) Sulfonmethane;
(12) Tiletamine and zolazepam or any salt thereof; other names for the tiletamine and zolazepam combination product include: telazol; other names for tiletamine include: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone; other names for zolazepam include: 4-(2-fluorophenyl)-6, 8-dihydro 1, 3, 8-trimethylpyrazolo - (3,4-e) (1,4)-diazepin-7 (1H)-one; flupyrazapon.
(c) Nalorphine.
(d) Ketamine.
(e) Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
(1) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
(2) Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(3) Not more than three hundred (300) milligrams of dihydrocodeinone (also known as hydrocodone), or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium;
(4) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts;
(5) Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(6) Not more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(7) Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(8) Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(f) Any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids, which means any drug or hormonal substance chemically and pharmacologically related to testosterone (other than estrogens, progestins and corticosteroids) that promotes muscle growth, unless listed in another schedule or excepted:
(1) Boldenone (dehydrotestosterone);
(2) Chlorotestosterone (clostebol, 4-chlorotestosterone, 4-chlortestosterone);
(3) Dehydrochlormethyltestosterone;
(4) Dihydrotestosterone (stanolone, 4-dihydrotestosterone);
(5) Drostanolone;
(6) Ethylestrenol;
(7) Fluoxymesterone;
(8) Formebulone (formebolone);
(9) Mesterolone;
(10) Methandienone (methandrostenolone);
(11) Methandriol;
(12) Methenolone;
(13) Methyltestosterone;
(14) Mibolerone;
(15) Nandrolone;
(16) Norethandrolone;
(17) Oxandrolone;
(18) Oxymesterone;
(19) Oxymetholone;
(20) Stanozolol;
(21) Testolactone;
(22) Testosterone;
(23) Trenbolone;
(24) Any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth;
(g) Any material compound, mixture or preparation which contains any quantity of pentazocine or its salts in oral dosage form;
(h) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product.
(B) Any material, compound, mixture or preparation which contains any quantity of a Schedule III controlled substance and is listed as an exempt substance in 21 C.F.R., Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.
SECTION 3. Section 41-29-119, Mississippi Code of 1972, is amended as follows:
41-29-119. (A) The controlled substances listed in this section are included in Schedule IV.
SCHEDULE IV
(a) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains limited quantities of the following narcotic drugs, or any salts thereof:
(1) Not more than one (1) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit;
(2) Dextropropoxyphene, including its salts (Darvon, Darvon-N; also found in Darvon compound and Darvocet-N, etc.).
(b) Any material, compound, mixture or preparation which contains any quantity of the following substances:
(1) Alprazolam;
(2) Barbital;
(3) Bromazepam;
(4) Butorphanol;
(5) Camazepam;
(6) Chloral betaine;
(7) Chloral hydrate;
(8) Chlordiazepoxide and its salts, but does not include chlordiazepoxide hydrochloride and clidinium bromide or chlordiazepoxide and esterified estrogens;
(9) Clobazam;
(10) Clonazepam;
(11) Clorazepate;
(12) Clotiazepam;
(13) Cloxazolam;
(14) Delorazepam;
(15) Diazepam;
(16) Estazolam;
(17) Ethchlorvynol;
(18) Ethinamate;
(19) Ethyl loflazepate;
(20) Fludiazepam;
(21) Flunitrazepam;
(22) Flurazepam;
(23) Halazepam;
(24) Haloxazolam;
(25) Ketazolam;
(26) Loprazolam;
(27) Lorazepam;
(28) Lormetazepam;
(29) Mazindol;
(30) Mebutamate;
(31) Medazepam;
(32) Meprobamate;
(33) Methohexital;
(34) Methylphenobarbital;
(35) Midazolam;
(36) Nimetazepam;
(37) Nitrazepam;
(38) Nordiazepam;
(39) Oxazepam;
(40) Oxazolam;
(41) Paraldehyde;
(42) Petrichloral;
(43) Phenobarbital;
(44) Pinazepam;
(45) Prazepam;
(46) Quazepam;
(47) Temazepam;
(48) Tetrazepam;
(49) Triazolam;
(50) Zaleplon;
(51) Zolpidem.
(c) Fenfluramine.
(d) Any material, compound, mixture or preparation which contains any quantity of the following substances:
(1) Diethylpropion;
(2) Phentermine;
(3) Pemoline (including any organometallic complexes or chelates thereof);
(4) Pipradrol;
(5) Sibutramine;
(6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane).
(e) Any material, compound, mixture or preparation which contains any quantity of the following substances:
(1) Cathine ((+/-) Norpseudoephedrine);
(2) Fencamfamin;
(3) Fenproporex;
(4) Mefenorex;
(5) Modafinil.
(B) Any material, compound, mixture or preparation which contains any quantity of a Schedule IV controlled substance and is listed as an exempt substance in 21 C.F.R., Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.
SECTION 4. This act shall take effect and be in force from and after July 1, 2001.